Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I bioequivalence study of K-924 (pitavastatin Ca/ezetimibe) in healthy adult males
jRCT2051250225Phase 1Completed
- Sponsor
- Kowa Company, Ltd.
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of pitavastatin and ezetimibe in hypercholesterolemia (2 arms), sponsored by Kowa Company, Ltd. Primary endpoint: Primary pharmacokinetic endpoints. Started Apr 2026; status: completed.
02
Drugs
pitavastatinezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on jRCT2051250225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051250225.